UBS analyst Karl Keirstead raised the firm’s price target on Oracle (ORCL) to $360 from $280 and keeps a Buy rating on the shares. Oracle’s pending growth acceleration is so material that the stock still works from here as the acceleration story plays out, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL: